These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Defibrination during warfarin therapy in a man with protein C deficiency. Francis RB; McGehee WG Thromb Haemost; 1985 Apr; 53(2):249-51. PubMed ID: 3839606 [TBL] [Abstract][Full Text] [Related]
23. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443 [TBL] [Abstract][Full Text] [Related]
24. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism]. Nielsen HK; Lassen JF; Ravn HB; Husted SE Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097 [TBL] [Abstract][Full Text] [Related]
25. [Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?]. Korte W; Corbetta C; Schmid L Schweiz Med Wochenschr; 1995 Mar; 125(9):420-3. PubMed ID: 7892570 [TBL] [Abstract][Full Text] [Related]
26. Therapy of acute thromboembolism with heparin and warfarin. Carter BL Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301 [TBL] [Abstract][Full Text] [Related]
27. Deep venous thrombosis and pulmonary embolism in pregnancy. Demers C; Ginsberg JS Clin Chest Med; 1992 Dec; 13(4):645-56. PubMed ID: 1478024 [TBL] [Abstract][Full Text] [Related]
28. [Heparin in deep venous thrombosis of the leg--effectiveness and safety]. Gatterer E; Stöllberger C; Slany J; Stöberl C; Jaksch J Wien Klin Wochenschr; 1988 Sep; 100(18):601-5. PubMed ID: 3188535 [TBL] [Abstract][Full Text] [Related]
29. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation. Ascani A; Iorio A; Agnelli G Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621 [TBL] [Abstract][Full Text] [Related]
34. Review of the initiation of anticoagulant therapy. Corbett NE; Peterson GM J Clin Pharm Ther; 1995 Aug; 20(4):221-4. PubMed ID: 8557786 [TBL] [Abstract][Full Text] [Related]
35. Heparin therapy in pediatric patients: a prospective cohort study. Andrew M; Marzinotto V; Massicotte P; Blanchette V; Ginsberg J; Brill-Edwards P; Burrows P; Benson L; Williams W; David M Pediatr Res; 1994 Jan; 35(1):78-83. PubMed ID: 8134203 [TBL] [Abstract][Full Text] [Related]
36. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Fennerty AG; Dolben J; Thomas P; Backhouse G; Bentley DP; Campbell IA; Routledge PA Clin Lab Haematol; 1987; 9(1):17-21. PubMed ID: 3581712 [TBL] [Abstract][Full Text] [Related]
37. [Occult pulmonary embolism in patients with proximal deep venous thrombosis]. Cuppini S; Cattelan AM; Casara D; Prandoni P Ann Ital Med Int; 1991; 6(1 Pt 1):1-5. PubMed ID: 1892723 [TBL] [Abstract][Full Text] [Related]
38. Clinically suspect pulmonary embolism after vein stripping. Lofgren EP; Coates HL; O'Brien PC Mayo Clin Proc; 1976 Feb; 51(2):77-80. PubMed ID: 1246161 [TBL] [Abstract][Full Text] [Related]
39. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet; 1992 Oct; 340(8824):873-6. PubMed ID: 1357297 [TBL] [Abstract][Full Text] [Related]
40. Prediction of heparin requirements in acute thromboplastic venous disease. Beaver BL; Young D; Satiani B Arch Surg; 1985 Apr; 120(4):436-8. PubMed ID: 3985788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]